AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Which Robo Advisor Outperformed In 2026 highlights top performers and the tactics behind their gains, plus notes on risk and diversification.
24,805 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Apple pushes to a fresh all-time high as AI-enabled products and a robust services ecosystem drive growth. The move w...
What if one cryptocurrency could outgrow Bitcoin and Ethereum combined? This article dives into the drivers, risks, a...
New to investing? This practical guide breaks down basic investment strategies for new investors into a simple, low-c...
Karman Holdings stock zoomed more than 6% today as the company was added to a major index. Here’s what happened, why ...
Jamie Dimon's JPMorgan Chase just delivered a striking quarterly message: big gains in equities trading and a higher ...
When a Federal Reserve chair signals a preference for policy stability over boom-and-bust cycles, it can upend how in...
Caterpillar has emerged as a heavyweight in the Dow, powered by AI-driven infrastructure demand and mining activity. ...
When netflix stock fell this past week, investors looked beyond headline results to the quality of communication from...
AI-driven demand is reshaping chip markets, but selecting the right names matters. This guide highlights five semicon...
An external review shows the Gates Foundation met with Jeffrey Epstein roughly 30 times between 2011 and 2014, despit...
Midday action hinges on Alphabet's report and the AI spend cycle. Learn what moves markets, how hyperscalers shape ri...